Oxbridge Re (NASDAQ:OXBR) Posts Quarterly Earnings Results

Oxbridge Re (NASDAQ:OXBRGet Free Report) posted its quarterly earnings results on Monday. The insurance provider reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.04, FiscalAI reports. Oxbridge Re had a negative net margin of 109.74% and a negative return on equity of 47.76%. The business had revenue of $0.58 million for the quarter, compared to analysts’ expectations of $0.70 million.

Here are the key takeaways from Oxbridge Re’s conference call:

  • SurancePlus tokenization and distribution progress — including entry into the Solana ecosystem and LayerZero/AlphaLedger connectivity across 160+ networks — meaningfully broadens investor access to on‑chain reinsurance and should support future growth.
  • Management recorded significant underwriting losses tied to Hurricane Milton, driving the combined ratio to a very high 264% for FY2025 and materially increasing expense and loss ratios versus the prior year.
  • Revenue improved to $2.58M for FY2025 (from $546k prior year) and the company narrowed its annual net loss to $2.08M (versus $2.73M), while the most recent quarter produced $120k net income, reflecting higher investment/other income and allocation of underwriting losses to token holders.
  • Strong liquidity position with approximately $6.9M in cash and restricted cash as of Dec 31, 2025, which management says supports tokenization initiatives and potential expansion into additional real‑world assets such as tokenized data center revenue.

Oxbridge Re Trading Down 7.3%

Shares of NASDAQ OXBR traded down $0.07 during trading on Monday, reaching $0.82. The company had a trading volume of 21,972 shares, compared to its average volume of 12,480. The stock has a market capitalization of $6.32 million, a PE ratio of -2.42 and a beta of 2.27. Oxbridge Re has a twelve month low of $0.76 and a twelve month high of $2.86. The stock has a 50-day moving average price of $1.04 and a two-hundred day moving average price of $1.38.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Oxbridge Re in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $5.00.

Check Out Our Latest Stock Analysis on Oxbridge Re

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Oxbridge Re stock. Virtu Financial LLC acquired a new position in shares of Oxbridge Re Holdings Limited (NASDAQ:OXBRFree Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 17,789 shares of the insurance provider’s stock, valued at approximately $32,000. Virtu Financial LLC owned about 0.23% of Oxbridge Re as of its most recent SEC filing. 5.64% of the stock is owned by institutional investors and hedge funds.

Oxbridge Re Company Profile

(Get Free Report)

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.

Read More

Earnings History for Oxbridge Re (NASDAQ:OXBR)

Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.